Zie tekst Engelstalige versie voor toelichting.
NB Trainingen kunnen zowel in het Nederlands als ook in de Engelse taal gegeven worden.
Nieuws
-
Swiss Medtech Sector Faces Uncertainty Amid U.S. Tariff Changes – Swiss Medtech and CH-REPs Call for Diplomatic and Regulatory Action
April 12, 2025 – The Swiss medical technology industry faces growing uncertainty following the U.S. government's recent decision to impose import tariffs on countries with trade surpluses. With a considerable surplus, Switzerland has been hit with a 31% tariff—significantly higher than many other nations. This move directly threatens the Swiss MedTech sector, which exported CHF 2.8 billion worth of medical technology products to the U.S. in 2023, making the U.S. the second most important market after the EU. Call for Action from Industry Leaders Swiss Medtech, the national association representing over 800 medical technology companies, has urgently called the Swiss…